Sacral Erector Spinae Plane Block for Catheter-Related Bladder Discomfort After HoLEP
Evaluation of the Effect of Bilateral Sacral Erector Spinae Plane Block on Postoperative Catheter-Related Bladder Discomfort in Patients Undergoing Holmium Laser Enucleation of the Prostate
Catheter-related bladder discomfort (CRBD) is common after holmium laser enucleation of the prostate (HoLEP). This single-center, randomized, controlled, assessor-blinded trial evaluates whether an ultrasound-guided bilateral sacral erector spinae plane (S-ESP) block performed before general anesthesia reduces the incidence of CRBD compared with general anesthesia alone in men aged 50 to 80 years undergoing elective HoLEP. The primary outcome is the incidence of CRBD at 1 hour after surgery.
調査の概要
状態
状態
条件
条件
介入・治療
介入・治療
詳細な説明
Catheter-related bladder discomfort (CRBD) is a common and distressing postoperative symptom complex in male patients undergoing Holmium Laser Enucleation of the Prostate (HoLEP), characterized by a suprapubic burning sensation, an urge to void, and involuntary bladder spasms due to three-way urinary catheterization and continuous bladder irrigation. The sacral erector spinae plane (S-ESP) block is an ultrasound-guided interfascial plane block that targets the S2-S4 sacral nerve roots, which provide both somatic (via the pudendal nerve) and visceral parasympathetic (via pelvic splanchnic nerves) innervation to the lower urinary tract. While current evidence regarding the efficacy of the S-ESP block against a no-block control group in HoLEP surgery is limited, blocking these sacral pathways may effectively modulate afferent bladder stimuli.
A total of 100 male patients aged 50 to 80 years with ASA physical status I-III scheduled for elective HoLEP surgery under general anesthesia will be randomly assigned in a 1:1 ratio to either the S-ESP block group (Group S, n=50) or the standard care control group (Group G, n=50) using computer-generated randomization and sealed opaque envelopes.
Patients in Group S will be placed in the prone position approximately 30 minutes before surgery under standard monitoring. Using a convex ultrasound transducer (GE HealthCare C1-5 probe) in a longitudinal paramedian orientation at the S2 intermediate sacral crest level, a 22G 80-100 mm echogenic block needle will be advanced in-plane in a craniocaudal direction into the fascial plane between the erector spinae aponeurosis and the sacral crest. Following hydrodissection with 1-2 mL normal saline and negative aspiration, 20 mL of 0.25% bupivacaine will be injected on each side (total 40 mL, 100 mg; not exceeding the maximum safe dose of 2 mg/kg). Sensory blockade will be assessed 30 minutes after block completion via pinprick testing over the bilateral S2-S4 dermatomes.
Both groups will receive a standardized general anesthesia protocol: induction with IV fentanyl (1 mcg/kg), propofol (2-2.5 mg/kg), and rocuronium (0.3 mg/kg) to facilitate laryngeal mask airway (LMA) insertion, followed by maintenance with 1 MAC sevoflurane and titrated remifentanil infusion (0.05-0.2 mcg/kg/min). Approximately 30 minutes before the end of surgery, all patients will receive IV paracetamol (1 g) and IV tramadol (100 mg) for multimodal analgesia, followed by routine postoperative IV paracetamol (1 g twice daily).
An independent anesthesiologist blinded to group allocation will assess postoperative outcomes at 30 minutes and at 1, 2, 4, 6, 12, and 24 hours. If the Visual Analog Scale (VAS) pain score is ≥4, IV tramadol (1 mg/kg, up to 400 mg/day) will be administered as rescue analgesia. If the CRBD score is ≥2 after excluding mechanical catheter obstruction, rescue antispasmodic or antimuscarinic medication will be administered. Quality of recovery will be evaluated at 24 hours using the validated Turkish version of the 15-item Quality of Recovery scale (QoR-15T).
研究の種類
研究の種類
入学 (推定)
入学
段階
段階
- 適用できない
連絡先と場所
研究連絡先
研究連絡先
- 名前:Kadriye Divrak, MD
- 電話番号:00905453712155
- メール:kadriyedivrak@gmail.com
研究連絡先のバックアップ
- 名前:Derya Ozkan, Prof., MD
- 電話番号:00905425843638
- メール:derya_z@yahoo.com
研究場所
-
-
-
Ankara、トルコ(Türkiye)、06170
- Ankara Etlik City Hospital
-
コンタクト:
- Kadriye Dıvrak, MD
- 電話番号:00905453712155
- メール:kadriyedivrak@gmail.com
-
-
参加基準
適格基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- Male patients aged between 50 and 80 years
- American Society of Anesthesiologists (ASA) physical status class I to III
- Scheduled for elective Holmium Laser Enucleation of the Prostate (HoLEP) surgery under general anesthesia
- Patients who agree to participate in the study and sign the written informed consent form
Exclusion Criteria:
- Age under 50 years or over 80 years
- ASA physical status class IV or higher
- Known hypersensitivity or allergy to local anesthetics
- History of chronic opioid use
- Chronic pain syndrome
- History of peripheral neuropathy, sacral neurological disease, or neurogenic bladder
- Overactive bladder or prominent preoperative bladder irritation symptoms
- History of previous prostate, bladder neck, or lower urinary tract surgery
- Active urinary tract infection
- Anticoagulant/antiplatelet use that contraindicates block administration according to current regional anesthesia guidelines, or clinically significant coagulopathy
- Infection or severe dermatological lesion at the block application site
- Severe renal failure (eGFR < 30 mL/min/1.73m2) or clinically significant hepatic failure
- Cognitive impairment, communication difficulty, or psychiatric/neurological condition preventing postoperative assessments
- Anticipated need for postoperative intensive care unit admission
- Presence of a preoperative indwelling urinary catheter
- Emergency surgery
- Patient refusal or withdrawal of consent
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:防止
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:独身
アーム数
武器と介入
参加者グループ / アーム参加者グループ / アーム |
介入・治療介入・治療 |
|---|---|
|
実験的:S-ESPB Group
Ultrasound-guided bilateral sacral erector spinae plane block with 20 mL of 0.25% bupivacaine per side, performed about 30 minutes before surgery, followed by standardized general anesthesia. |
Ultrasound-guided bilateral sacral erector spinae plane block with 20 mL of 0.25% bupivacaine per side, performed about 30 minutes before surgery, followed by standardized general anesthesia |
|
アクティブコンパレータ:Standard Care Group
Standardized general anesthesia without any block or sham injection. |
Standardized general anesthesia without any block. |
この研究は何を測定していますか?
主要な結果の測定
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Incidence of Catheter-Related Bladder Discomfort (CRBD) at Postoperative 1 Hour
時間枠:1 hour after surgery
|
CRBD is graded on a 4-point scale: 0 = none; 1 = mild (reported only on questioning); 2 = moderate (reported spontaneously, without behavioral responses); 3 = severe (reported spontaneously with behavioral responses such as strong verbal response, flailing limbs or attempts to remove the catheter). Incidence is the proportion of patients with a score of 1 or higher. |
1 hour after surgery
|
二次結果の測定
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Incidence of CRBD at other time points
時間枠:30 minutes and 2, 4, 6, 12 and 24 hours after surgery
|
Proportion of patients with CRBD score of 1 or higher |
30 minutes and 2, 4, 6, 12 and 24 hours after surgery
|
|
Severity of CRBD
時間枠:30 minutes and 1, 2, 4, 6, 12 and 24 hours after surgery
|
CRBD severity will be graded on a 4-point ordinal scale from 0 (none) to 3 (severe). Moderate-to-severe CRBD is defined as a score ≥2. |
30 minutes and 1, 2, 4, 6, 12 and 24 hours after surgery
|
|
Postoperative pain score
時間枠:30 minutes and 1, 2, 4, 6, 12 and 24 hours after surgery
|
Postoperative pain intensity will be assessed using a 10-cm Visual Analog Scale (VAS) ranging from 0 (no pain) to 10 (worst pain). |
30 minutes and 1, 2, 4, 6, 12 and 24 hours after surgery
|
|
Intraoperative remifentanil consumption
時間枠:Intraoperative period
|
Total amount of intraoperative remifentanil consumed, recorded in micrograms (mcg) and normalized to body weight and duration (mcg/kg/hour). |
Intraoperative period
|
|
Total Postoperative Rescue Analgesic Consumption
時間枠:First 24 hours after surgery
|
Total intravenous tramadol dose in milligrams |
First 24 hours after surgery
|
|
Time to First Rescue Analgesic Request
時間枠:First 24 hours after surgery
|
Minutes from end of surgery to first rescue tramadol dose |
First 24 hours after surgery
|
|
Antispasmodic or antimuscarinic requirement
時間枠:First 24 hours after surgery
|
Proportion of patients requiring additional antispasmodic or antimuscarinic medication for persistent moderate-to-severe CRBD (score ≥2) |
First 24 hours after surgery
|
|
Incidence of Postoperative Nausea and Vomiting (PONV) and Other Adverse Events
時間枠:First 24 hours after surgery
|
Number and percentage of participants experiencing postoperative nausea and vomiting (PONV) or any block- or anesthesia-related adverse events. |
First 24 hours after surgery
|
|
Postoperative Quality of Recovery Score (QoR-15T)
時間枠:At 24 hours after surgery
|
Quality of recovery will be evaluated using the validated Turkish version of the 15-item Quality of Recovery scale (QoR-15T). Total scores range from 0 to 150, with higher scores indicating better postoperative recovery quality. |
At 24 hours after surgery
|
協力者と研究者
捜査官
捜査官
- スタディディレクター:Derya Ozkan, Prof., MD、Ankara Etlik City Hospital
出版物と役立つリンク
一般刊行物
- Wang SY, Qiu Q, Shen X. Effect of Pudendal Nerve Block on the Prevention of Postoperative Bladder Spasm and Catheter-Related Bladder Discomfort in Male Patients Undergoing Transurethral Holmium Laser Enucleation of the Prostate. Clin Interv Aging. 2022 Nov 30;17:1729-1738. doi: 10.2147/CIA.S384612. eCollection 2022.
- Dost B, Narayanan M, Marrone F, De Cassai A, Tulgar S, Aksu C, Merjavy P, Chin KJ. The Sacral Erector Spinae Plane Block: A Narrative Review. Pain Ther. 2026 Feb;15(1):131-147. doi: 10.1007/s40122-025-00807-6. Epub 2025 Dec 23.
- Rinaldi P, Garo ML. Efficacy and safety of sacral erector spinae plane (S-ESP) block in adult and pediatric patients during surgical procedures: A comprehensive systematic review and meta-analysis. J Clin Anesth. 2026 Apr;111:112181. doi: 10.1016/j.jclinane.2026.112181. Epub 2026 Mar 11.
- Akkaya T, Ozkan D, Karakoyunlu N, Ergil J, Gumus H, Ersoy H, Comert A, Acar HI, Yildiz S. Pudendal block in transurethral prostatectomy: A randomised trial. Eur J Anaesthesiol. 2015 Sep;32(9):656-7. doi: 10.1097/EJA.0000000000000172. No abstract available.
- Olgun Keles B, Tekir Yilmaz E, Altinbas A. Comparison between the Efficacy of Sacral Erector Spina Plane Block and Pudendal Block on Catheter-Related Bladder Discomfort: A Prospective Randomized Study. J Clin Med. 2024 Jun 20;13(12):3617. doi: 10.3390/jcm13123617.
研究記録日
主要日程の研究
研究開始 (推定)
研究開始
一次修了 (推定)
一次修了
研究の完了 (推定)
研究の完了
試験登録日
最初に提出
最初に提出
QC基準を満たした最初の提出物
QC基準を満たした最初の提出物
最初の投稿 (実際)
最初の投稿
学習記録の更新
投稿された最後の更新 (実際)
投稿された最後の更新
QC基準を満たした最後の更新が送信されました
QC基準を満たした最後の更新が送信されました
最終確認日
最終確認日
詳しくは
本研究に関する用語
追加の関連 MeSH 用語
その他の研究ID番号
その他の研究ID番号
- AEŞH-EK-2026-180
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
All personal data will be anonymized and individual participant data will not be made publicly available in accordance with institutional ethics committee approval.
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。